Medical problems

Published on 11/04/2015 by admin

Filed under Surgery

Last modified 11/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 1 (1 votes)

This article have been viewed 1959 times

8

Medical problems

Introduction

General surgical operations are now performed on patients who are older, more frail and with significant and often multiple (medical) co-morbidities, so it becomes even more important to appreciate and consider these ‘medical’ conditions. Rates of deaths and complications after abdominal surgery have been the subject of a report by the Royal College of Surgeons of England (at: www.rcseng.ac.uk/publications/docs/higher-risk-surgical-patient). A high-risk patient is defined as one whose estimated risk of mortality is greater than 5%, and includes any patient over the age of 65 years undergoing major gastrointestinal or vascular surgery, and any patient over 50 years with diabetes mellitus or renal impairment. Recommendations include preoperative risk assessment with a tailored management plan directed by consultant surgeons and anaesthetists, and rapid identification and treatment of postoperative infection.

‘Medical’ disorders appear in surgical practice in four main ways:

• A pre-existing medical condition may precipitate a surgical admission because of exacerbation, progression or complications of the condition: for example, foot problems in diabetes

• A pre-existing medical condition may be made worse by operation. In chronic obstructive pulmonary disease, for example, general anaesthesia and postoperative sputum retention may precipitate life-threatening pneumonia

• A surgical condition may be complicated by an unrelated medical disorder. For example, a patient with rheumatoid arthritis on steroid therapy is vulnerable to impaired healing and recurrent infection

• An occult condition can become manifest under the stress of anaesthesia and operation. For example, perioperative or postoperative myocardial infarction can be caused by occult ischaemic heart disease

Cardiac and cerebrovascular disease

Emergency surgery in patients with cardiac disease is about four times more likely to result in death than the same operation done electively. Thus, preoperative assessment is vitally important in emergency patients so any cardiac condition can be recognised and stabilised, electrolyte imbalances corrected and appropriate anaesthesia, surgical technique, monitoring and aftercare employed to minimise risk.

1 Ischaemic heart disease

The clinical manifestations of ischaemic heart disease are:

Asymptomatic coronary artery disease may progress to infarction under anaesthetic and surgical stresses, including laryngoscopy and endotracheal intubation, pain, hypoxia, rapid blood loss, anaemia, hypotension, hypocarbia and fluid overload. For major operations, general anaesthesia and spinal anaesthesia carry similar risks. Local anaesthesia, when practicable, is much safer.

Clinical problems

a: Stable angina and myocardial infarction more than three months previously There is usually little increased risk during operation and exercise tolerance is by far the most important indicator of the patient’s ability to tolerate anaesthesia and surgery. This can be assessed in the history (remembering that exercise tolerance may be limited by mobility problems rather than cardiorespiratory problems). Formal assessment on a treadmill may be helpful, and occasionally coronary angiography is required to fully assess cardiac risk.

In general, all cardiac medication should be continued perioperatively. Nitrates, which dilate the coronary arteries and reduce preload and left ventricular work, may reduce cardiac ischaemia during general anaesthesia and should not be stopped in the perioperative period. A transdermal nitrate patch is a useful alternative to tablets or sprays. Beta-adrenergic blockers, which reduce cardiac work and oxygen demand, should be continued unless non-ischaemic cardiac failure develops. Most patients will be taking aspirin (and some clopidogrel in addition), and the risks of bleeding have to be weighed against the risks of stopping anti-platelet treatment.

b: Acute coronary syndrome (ACS) This is a term applied to a spectrum of conditions from unstable angina to non-ST-elevation myocardial infarction (NSTEMI) to ST-elevation myocardial infarction (STEMI). Acute coronary syndrome associated with surgery usually occurs during the first few days after operation, particularly on the second to fourth postoperative nights, rather than during the operation. Typical chest pain is not always a feature and postoperative ACS may present ‘silently’ (i.e. painlessly) with otherwise unexplained hypotension, cardiac failure, arrhythmias or cardiac arrest, particularly in patients with diabetes. Diagnosis is made on the basis of at least two of the following: appropriate symptoms (particularly typical cardiac ischaemic pain); a significant rise in a cardiac biomarker, usually troponin; and ECG changes consistent with ischaemia (dynamic changes including ST depression, T-wave flattening or inversion) or infarction (ST elevation). It is always helpful to have a preoperative ECG for comparison which should be performed on all patients over 50 years of age and any with cardiac symptoms or signs.

Troponin is a very specific marker of myocardial damage, but be aware that this damage may result from conditions other than ischaemia or infarction due to coronary artery disease, e.g. sepsis, hypotension or heart failure, and therefore the management may differ from that of ACS.

The medical treatment of ACS includes aspirin, clopidogrel (for anti-platelet activity) and fractionated heparin (given subcutaneously). These drugs adversely effect clotting in the perioperative period and the ‘harm/benefit’ balance requires negotiation between cardiology and surgical teams. Other treatments such as nitrate and beta-adrenergic receptor blockade are less likely to have adverse ‘surgical’ effects. ST-elevation myocardial infarction is ideally treated by emergency primary revascularisation but this depends on the ‘surgical’ stability of the patient, and on how close the nearest coronary intervention centre is. Thrombolysis is an option, but the potential salvage of myocardium has to be weighed against the serious risk of major haemorrhage.

2 Chronic heart failure (CHF)

This is a complex clinical syndrome with symptoms and signs resulting from impairment of the heart as a pump due to structural or functional abnormalities. The severity of heart failure correlates poorly with objective measurements of heart function (such as ejection fraction), such that up to 50% of patients presenting with symptoms and signs of heart failure will have ‘preserved ejection fraction’ (previously called ‘diastolic heart failure’). Assessment of severity is based on clinical features, particularly when exercise tolerance is limited (New York Heart Association classification). Patients with renal impairment or electrolyte abnormalities have a poorer prognosis and tend to decompensate more readily with operative stress.

Most patients will be taking diuretics, an angiotensin converting enzyme (ACE) inhibitor and a beta-blocker as first line treatment, and nitrates and digoxin if the condition is more severe, and these treatments should be continued if possible.

Patients with CHF should be optimised before major surgery, but there is still an increased mortality of up to 5%. The causes, symptoms and signs of cardiac failure are shown in Figure 8.1.

Clinical problems

Preoperative assessment of cardiac failure

Chest X-ray may demonstrate cardiomegaly and there may be signs of pulmonary oedema including upper lobe diversion, hilar congestion, septal Kerley B lines and pleural effusions (see Fig. 8.1). ECG may show an arrhythmia, myocardial ischaemia, ventricular hypertrophy, left bundle branch block or loss of R waves.

Left ventricular function can be assessed by echocardiography and documented more precisely by radionuclide studies using multiple gated acquisition (MUGA), but the best assessment is a clinical one based on exercise tolerance. Measurement of blood urea and electrolytes is important as baseline and also indication of severity of the condition.

If there is any doubt about the fitness of a patient for operation, a cardiological opinion should be sought.

3 Cardiac arrhythmias

Clinical problems

a: Atrial fibrillation (Fig. 8.2) Pre-existing (preoperative) atrial fibrillation is usually secondary to ischaemic heart disease but may be caused by mitral valve disease or thyrotoxicosis. Atrial fibrillation with a controlled ventricular rate (i.e. a pulse rate of less than 90 beats per minute at rest) causes minimal extra risk. An uncontrolled ventricular rate may cause perioperative heart failure. Atrial fibrillation (even with a controlled ventricular response) increases the risk of arterial embolism from any thrombus present in the left atrium. Adequate control of ventricular rate should be achieved before operation with beta-blocker and digoxin, occasionally supplemented with verapamil or amiodarone. Digoxin can be given intravenously if rapid control is necessary but potassium levels need to be monitored closely as digoxin given in the presence of hypokalaemia can lead to further arrhythmias. If the patient is anticoagulated with warfarin, there is a small risk of excessive bleeding at operation; stabilising the international normalised ratio (INR) between 1.5 and 2.5 may be the safest option. Another alternative is to stop warfarin and change to heparin.

Acute onset of AF postoperatively may be due to a major surgical (e.g. anastomotic leakage after bowel resection) or medical (e.g. pneumonia) complication (Fig. 8.2). If the onset of atrial arrhythmia (particularly atrial fibrillation) is associated with right bundle branch block on the ECG, this suggests a diagnosis of pulmonary embolism.

b: Bradycardia Bradycardia is common in young fit athletic patients and is not a problem. In patients taking beta-blockers or digoxin, if the apex rate is below 60 beats per minute, that day’s dose should be omitted and the regular dose reviewed.

Bradycardia may be caused by complete heart block, which should be easily diagnosed on the ECG. This may require urgent temporary transvenous pacing, particularly when there is significant haemodynamic compromise.

If a patient has a cardiac pacemaker, it is important to know the reason for its insertion: is the patient pacemaker-dependent, has the pacemaker been checked recently, what type of pacemaker has been inserted? Surgical diathermy, particularly monopolar diathermy, can interfere with the pacemaker if the current flows close to the heart. Ideally, bipolar diathermy should be used if diathermy is required. In addition a strong magnet should be available; if placed over the pacemaker this will return the rate to 100 beats/min.

4 Hypertension

About one in four patients coming to surgery is either hypertensive or is receiving antihypertensive therapy. Most have ‘essential’ hypertension, but causes such as renal artery stenosis and phaeochromocytoma must be considered in patients presenting with raised blood pressure which has not been appropriately investigated. (For other causes see Fig. 8.3.) Undiagnosed renal artery stenosis puts the patient at risk of severe acute kidney injury if there is an episode of hypotension, and phaeochromocytoma of potentially fatal hypertensive crisis.

Clinical problems

5 Cerebrovascular disease

A patient has cerebrovascular disease if there is a history of stroke or transient ischaemic attacks (TIAs). Cerebral atherosclerosis may render the blood flow to the brain precarious, with an increased risk of perioperative stroke from hypoxia, hypotension or increased blood viscosity resulting from dehydration.

Patients with ischaemic heart disease or peripheral vascular disease should also be assumed to have cerebrovascular disease and, as a minimum, the carotid arteries should be auscultated for bruits. In high-risk patients, or if a carotid bruit is present, a duplex Doppler examination of the carotid arteries should be performed, and patients with a stenosis greater than 70% considered for carotid endarterectomy before the planned operation if conditions permit. The anaesthetist should be warned of any signs or symptoms suggestive of carotid artery disease so that special care can be taken to avoid hypotension during surgery.

After a stroke, operation should be avoided for at least 2 months if practicable. This is because autoregulation of cerebral blood pressure becomes disrupted, so that cerebral arterial pressure becomes directly related to systemic arterial pressure. Brain perfusion thus loses the buffering effect of autoregulation on peaks and troughs of blood pressure that tend to occur during anaesthesia and surgery. If operation cannot be delayed, it is important to prevent hypertension and hypotension in the perioperative period.

There are few other measures likely to reduce cerebrovascular complications in patients with cerebrovascular disease, although there is an argument for prescribing low-dose aspirin (75 mg daily) to inhibit platelet aggregation. The surgeon needs to be involved in any decision to stop or start aspirin; in any case, this needs to be stopped at least a week before major surgery to reduce the risk of excessive bleeding.

6 Valvular heart disease

The common valvular abnormalities are mitral regurgitation, aortic stenosis and aortic regurgitation. Any of these may dangerously alter cardiovascular dynamics, but stenotic lesions are more serious than regurgitant ones, as the cardiac output tends to be fixed.

Under perioperative stress, valvular disease may precipitate acute myocardial ischaemia, hypotension, cardiac failure, arrhythmias or thromboembolism. Valvular heart disease also predisposes to infective endocarditis.

Aortic stenosis

Aortic stenosis is potentially the most serious valvular disorder in a surgical patient because it limits the cardiac output and reduces blood flow to the coronary arteries. Indeed, the patient may already be functioning close to the limit with almost no reserve. Perioperative hypotension and tachycardia can be life-threatening in such cases. Aortic ‘sclerosis’ produces a similar ejection systolic murmur and is caused by fixed, rigid valve leaflets, usually with systolic hypertension. The perioperative risk is that of the hypertension and arterial disease.

In a patient with an ejection systolic murmur, any associated cardiac symptoms may help identify the murmur as pathological, e.g. a history of syncope, angina or shortness of breath on exertion. Note, however, that any systolic murmur is difficult to categorise clinically, particularly in the elderly, and an echocardiogram must be performed to identify the valvular cause and offer an assessment of severity. A specialist cardiology assessment may also be required.

Clinical signs of aortic stenosis are:

If aortic stenosis is suspected, an echocardiogram will confirm the diagnosis and aid assessment of severity by measuring the aortic valve area, the gradient across the valve and an estimate of left ventricular systolic function.

Non-urgent surgery may be best delayed until after operative intervention to the aortic valve. This may now be carried out percutaneously in frail or elderly patients in whom previously the risk of valve replacement was prohibitive.

Symptomatic valvular disease is potentially dangerous and requires full preoperative assessment and treatment. Major valvular heart disease may be discovered in recent immigrants from developing countries where rheumatic heart disease is prevalent. Patients with valvular heart disease require cardiac monitoring during operation and usually intensive care afterwards.

Patients with mechanical valves are usually maintained on permanent warfarin anticoagulation and it is important to maintain this to prevent valve thrombosis, a potentially fatal condition. Patients with bioprosthetic valves (pig valves) do not usually require anticoagulation.

It should be remembered that warfarin is intended to minimise intravascular thrombosis and does not affect the extrinsic thrombotic mechanisms. For many operations it is safe to continue warfarin therapy as long as the INR is maintained in the lower therapeutic range (INR 1.5–2.5). For major surgery where much bleeding is anticipated, some surgeons prefer to stop warfarin 2 days before operation and substitute subcutaneous heparin or an intravenous infusion. For patients with mitral valve prostheses where the risk of thrombosis is high, full heparinisation must be carefully maintained throughout the perioperative period. However, heparin anticoagulation is more brittle than warfarin and carries a greater risk of over-anticoagulation and potential haemorrhage. For other patients, heparin can be stopped 12 hours before operation and restarted once the danger of bleeding is over. The advantage of heparin over warfarin is that its effects can be quickly reversed by stopping the infusion or with protamine if bleeding is excessive. However, rapid reversal may precipitate thrombosis.

In all cases it is advisable to involve the haematologist in discussion for advice on management, and in anticipation of specific treatment.

Infective endocarditis and indications for antibiotic prophylaxis

Valvular disease, and in particular prosthetic replacement valves, carry a risk of infective endocarditis. When blood is forced under pressure through a narrow orifice, laminar flow is disrupted and eddy currents predispose to local thrombus formation and deposition of circulating bacteria. The vegetations of infective endocarditis thus form on the low-pressure side of the jet of blood passing through a damaged valve or a ventricular septal defect. The left side of the heart is more susceptible than the right because of the higher pressures and greater potential for turbulence.

Streptococcus viridans is the most common causative organism of infective endocarditis. Other bacteria, such as coliforms or fungi, e.g. Candida, may also be responsible. Many types of operation and some invasive investigations cause transient bacteraemia. Although the incidence of infective endocarditis following such procedures is small, the consequences can be catastrophic. The efficacy of prophylactic antibiotics is not absolutely proven, but they are all that is available. The relative risks associated with various cardiac and valvular lesions are summarised in Figure 8.4. The procedures most likely to cause bacteraemia are also shown in Figure 8.4.

The choice of prophylactic antibiotics and the dose regimen depend on the anticipated organisms, the operative procedure and local protocols.

Respiratory diseases

Respiratory complications (mainly atelectasis and pneumonia) occur in as many as 15% of surgical patients and are the leading cause of postoperative mortality in the elderly. The risk of a respiratory complication increases with the increasing duration of anaesthetic and is amplified by pre-existing respiratory disease such as chronic obstructive pulmonary disease, asthma or bronchiectasis. Other important factors include smoking, cardiac failure, obesity, old age and general debility. Good postoperative pain relief allows the patient to breathe deeply and cough, which, along with effective physiotherapy, helps reduce the risk of respiratory complications.

Clinical problems

a Chronic obstructive pulmonary disease (COPD)

COPD (smoking-related lung disease—chronic bronchitis and emphysema) is common and strongly predisposes to postoperative respiratory complications, particularly bronchopneumonia, lobar collapse and pneumothorax. There is often a degree of reversible bronchoconstriction, and this can be assessed before operation by measuring peak expiratory flow before and after bronchodilator treatment. Many patients will already have had spirometry and vitalography in family practice or in specialist hospital COPD services and their treatment optimised. Otherwise preoperative assessment by the hospital ‘chest team’ will help bring the patient into optimum health. The forced expiratory volume in 1 second (FEV1) is perhaps the single most useful assessment of severity of chronic lung disease.

Other chronic lung diseases include bronchiectasis, pneumoconiosis, pulmonary fibrosis, sarcoidosis and pulmonary tuberculosis.

b Cigarette smoking

Buy Membership for Surgery Category to continue reading. Learn more here